Establishing an innovative class of polyomavirus antivirals spanning BK and JC virus indications CANTON, Mass.--(BUSINESS ...

The Company announced the development of the first antiviral to combat BK virus, one of the most common viral infections in transplant patients CANTON, Mass.--(BUSINESS WIRE)--Orthogon Therapeutics ...

CANTON, Mass.--(BUSINESS WIRE)--Orthogon Therapeutics LLC, a drug development company focused on designing innovative antivirals and anti-infective therapeutics, announced that it has raised an $8M ...

The MyGenius PRO development was a collaboration between ELITechGroup and Hitachi High-Tech.

A empresa anunciou hoje o fechamento de um financiamento adicional de US$ 11 milhões, elevando o capital total levantado para ...

Orthogon’s small molecule therapeutics redefine treatment possibilities for BK virus infections. CANTON, Mass.–(BUSINESS WIRE)–December 10, 2024– Orthogon Therapeutics, a developer of novel antiviral ...

Orthogon Therapeutics a annoncé aujourd’hui la clôture d’un tour de table de 11 millions de dollars, portant le montant total ...

Scientists think a very common childhood infection may be linked to bladder cancer — and now, they're figuring out the chain reaction that connects the two diseases. It's known that people who get ...

Asahi Kasei acquires Aicuris, adding three antiviral assets targeting immunocompromised patients, with combined revenue ...

When Tim Tavender developed a common virus, he had no idea it was the start of what would later become a cancer diagnosis. The 51-year-old from Southampton became ill with BK virus, also known as ...

Tackling a common childhood virus could open the door to preventing bladder cancer, according to new research funded by Kidney Research UK and York Against Cancer. The study, published in Science ...

Tackling a common childhood virus could open the door to preventing bladder cancer, according to new research. The study, published in Science Advances by Dr. Simon Baker and colleagues at the ...